Research use, legality and safety
What “research use only” means, why that matters, and how to read safety signals in the literature.
Regulatory status
A few peptides (semaglutide, tirzepatide, tesamorelin, bremelanotide) are approved medicines in specific formulations. Most compounds on this site are not approved for human use anywhere and are sold as research chemicals. Laws vary by country; it is your responsibility to know them.
What third-party testing shows
A certificate of analysis (CoA) from an independent lab reports purity (typically by HPLC) and identity (by mass spectrometry) for a specific lot. It does not establish sterility or endotoxin levels unless those tests are listed. Lot traceability lets a result be tied to the vial in hand. N1 Aminos publishes CoAs on request for every batch.
Reading safety signals
Animal data do not transfer directly to humans. Pay attention to route (oral vs injected), dose per kilogram, and duration. Recurrent signals worth knowing: GI effects and gallbladder issues with GLP-1 analogs; water retention, numbness and blood-glucose changes with GH secretagogues; nausea and cardiovascular effects with melanotan II; hypotension with some vasodilatory peptides.
The role of a clinician
Nothing here replaces medical supervision. Blood work before and during a protocol, a review of interactions with current medication, and a plan for stopping are standard in any clinical peptide use.